Nibrin is a marker of clinical outcome in patients with advanced serous ovarian cancer treated in the phase III OVA-301 trial
| Image |  |
|---|---|
| Description | scientific article published on 5 November 2013 |
| Author/s |
author: Bradley J. Monk |
| Publication date | November 5, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |